AIM ImmunoTech greenlit to import chronic fatigue syndrome drug into Argentina
Автор: Proactive Investors
Загружено: 2020-06-22
Просмотров: 1156
Описание:
AIM ImmunoTech Inc (NYSEAMERICAN:AIM) CEO Tom Equels tells Proactive the Florida-based biotech has received approval from Argentinian regulators to import its myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) drug Ampligen.
Equels says the company recently got a nod from the FDA to export the drug to Argentina for commercial sale, adding that Ampligen is the only drug approved for severe CFS anywhere in the world.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: